Cargando…
Persistent increase in cardiac troponin I in Fabry disease: a case report
BACKGROUND: Hypertrophic cardiomyopathy is a frequent manifestation in Fabry disease (FD) - an X-linked lysosomal storage disorder caused by reduced activity of the enzyme α-galactosidase A. In FD an elevation of specific cardiac biomarkers, such as cardiac troponin I (cTNI) has been reported in cas...
Autores principales: | Tanislav, Christian, Feustel, Andreas, Franzen, Wolfgang, Wüsten, Oliver, Schneider, Christian, Reichenberger, Frank, Rolfs, Arndt, Sieweke, Nicole |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3039626/ https://www.ncbi.nlm.nih.gov/pubmed/21281467 http://dx.doi.org/10.1186/1471-2261-11-6 |
Ejemplares similares
-
Continuous Cardiac Troponin I Release in Fabry Disease
por: Feustel, Andreas, et al.
Publicado: (2014) -
Cardiac Troponin I elevation after epileptic seizure
por: Sieweke, Nicole, et al.
Publicado: (2012) -
Cardiac Troponin I: A Valuable Biomarker Indicating the Cardiac Involvement in Fabry Disease
por: Tanislav, Christian, et al.
Publicado: (2016) -
Fabry Disease – Underestimated in the Differential Diagnosis of Multiple Sclerosis?
por: Böttcher, Tobias, et al.
Publicado: (2013) -
Factors associated with shunt dynamic in patients with cryptogenic stroke and patent foramen ovale: an observational cohort study
por: Tanislav, Christian, et al.
Publicado: (2011)